{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T05:26:01Z","timestamp":1737955561741,"version":"3.33.0"},"reference-count":54,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>The objective of this retrospective observational study was to estimate the prevalence of actinic keratosis (AK) in individuals aged \u2265\u200940 years in France, to describe the characteristics of affected patients, and to describe treatments. A representative panel of 20,000 households with \u2265\u20091 member aged \u2265\u200940 years were invited to participate. Participants who reported AK lesions diagnosed by a physician were eligible. The study questionnaire collected data on demographics, lesion characteristics, Fitzpatrick phototype, diagnosis, and treatments. In total, 15,246 questionnaires (78.5%) were returned and 639 responders were eligible. The adjusted prevalence of AK was 4.03% (95% CI: 3.73\u20134.35). Prevalence is probably underestimated due to data collection by self-report and low awareness of AK. 177 participants (27.7%) were aged &lt;\u200965 years. AK was diagnosed by a dermatologist for 521 participants (81.6%). Some 200 participants (31.3%) had no lesions at the time of the survey and 243 (37.9%) had never been treated; 312 participants (78.6%) were prescribed physical treatment, principally cryotherapy; and 125 (31.5%) were prescribed topical treatment, principally 5-fluorouracil or imiquimod. In conclusion, improving diagnosis of AK in everyday clinical practice is important to ensure that all individuals with AK are treated optimally and encouraged to take sun protection measures to prevent progression to SCC.<\/jats:p>","DOI":"10.2340\/actadv.v105.42372","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T10:09:02Z","timestamp":1737886142000},"page":"adv42372","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and Management of Actinic Keratosis in France: A General Population Survey (REAKT)"],"prefix":"10.2340","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5574-5825","authenticated-orcid":false,"given":"Brigitte","family":"Dr\u00e9no","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7565-2255","authenticated-orcid":false,"given":"Pierre","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Caillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-5464","authenticated-orcid":false,"given":"Chantal","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Amici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,1,26]]},"reference":[{"key":"89065","doi-asserted-by":"crossref","unstructured":"de Oliveira ECV, da Motta VRV, Pantoja PC, Ilha CSO, Magalh\u00e3es RF, Galadari H, et al. Actinic keratosis - review for clinical practice. Int J Dermatol 2019; 58: 400-407.","DOI":"10.1111\/ijd.14147"},{"key":"89066","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ijd.14147","DOI":"10.1111\/ijd.14147"},{"key":"89067","doi-asserted-by":"crossref","unstructured":"Rosen T, Lebwohl MG. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol 2013; 68: S2-9.","DOI":"10.1016\/j.jaad.2012.09.052"},{"key":"89068","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2012.09.052","DOI":"10.1016\/j.jaad.2012.09.052"},{"key":"89069","doi-asserted-by":"crossref","unstructured":"Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol 2013; 169: 502-518.","DOI":"10.1111\/bjd.12420"},{"key":"89070","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.12420","DOI":"10.1111\/bjd.12420"},{"key":"89071","doi-asserted-by":"crossref","unstructured":"Reinehr CPH, Bakos RM. Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects. An Bras Dermatol 2019; 94: 637-657.","DOI":"10.1016\/j.abd.2019.10.004"},{"key":"89072","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.abd.2019.10.004","DOI":"10.1016\/j.abd.2019.10.004"},{"key":"89073","unstructured":"Goldenberg G, Perl M. Actinic keratosis: update on field therapy. J Clin Aesthet Dermatol 2014; 7: 28-31."},{"key":"89074","unstructured":"Feldman SR, Fleischer AB, Jr. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis 2011; 87: 201-207."},{"key":"89075","doi-asserted-by":"crossref","unstructured":"Fernandez Figueras MT. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited. J Eur Acad Dermatol Venereol 2017; 31: 5-7.","DOI":"10.1111\/jdv.14151"},{"key":"89076","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.14151","DOI":"10.1111\/jdv.14151"},{"key":"89077","doi-asserted-by":"crossref","unstructured":"Bernard P, Dupuy A, Sasco A, Brun P, Duru G, Nicoloyannis N, et al. Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: a cross-sectional survey. Dermatology 2008; 216: 194-199.","DOI":"10.1159\/000112925"},{"key":"89078","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000112925","DOI":"10.1159\/000112925"},{"key":"89079","doi-asserted-by":"crossref","unstructured":"Reach G, Pellan M, Crine A, Touboul C, Ciocca A, Djoudi Y. Holistic psychosocial determinants of adherence to medication in people with type 2 diabetes. Diabetes Metab 2018; 44: 500-507.","DOI":"10.1016\/j.diabet.2018.06.001"},{"key":"89080","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.diabet.2018.06.001","DOI":"10.1016\/j.diabet.2018.06.001"},{"key":"89081","doi-asserted-by":"crossref","unstructured":"Briot K, Grange L, Cortet B, Feron JM, Chauvin P, Coulomb A, et al. Real-world care for individuals aged over fifty with fractures in France: evidence for a wide care gap - The EPIFRACT Study. Joint Bone Spine 2020; 87: 467-473.","DOI":"10.1016\/j.jbspin.2020.04.007"},{"key":"89082","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jbspin.2020.04.007","DOI":"10.1016\/j.jbspin.2020.04.007"},{"key":"89083","doi-asserted-by":"crossref","unstructured":"Mosnier-Pudar H, Hochberg G, Eschwege E, Halimi S, Virally ML, Guillausseau PJ, et al. How patients' attitudes and opinions influence self-care behaviours in type 2 diabetes. Insights from the French DIABASIS Survey. Diabetes Metab 2010; 36: 476-483.","DOI":"10.1016\/j.diabet.2010.08.004"},{"key":"89084","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.diabet.2010.08.004","DOI":"10.1016\/j.diabet.2010.08.004"},{"key":"89085","doi-asserted-by":"crossref","unstructured":"Cortet B, Chauvin P, Feron JM, Grange L, Coulomb A, Launois R, et al. Fragility fractures in France: epidemiology, characteristics and quality of life (the EPIFRACT study). Arch Osteoporos 2020; 15: 46.","DOI":"10.1007\/s11657-019-0674-2"},{"key":"89086","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s11657-019-0674-2","DOI":"10.1007\/s11657-019-0674-2"},{"key":"89087","unstructured":"Charles MA, Basdevant A, Eschwege E. [Prevalence of obesity in adults in France: the situation in 2000 established from the OBEPI Study]. Ann Endocrinol (Paris) 2002; 63: 154-158."},{"key":"89088","doi-asserted-by":"crossref","unstructured":"Charles MA, Eschwege E, Basdevant A. Monitoring the obesity epidemic in France: the Obepi surveys 1997-2006. Obesity (Silver Spring) 2008; 16: 2182-2186.","DOI":"10.1038\/oby.2008.285"},{"key":"89089","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/oby.2008.285","DOI":"10.1038\/oby.2008.285"},{"key":"89090","doi-asserted-by":"crossref","unstructured":"Eschwege E, Basdevant A, Crine A, Moisan C, Charles MA. Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey. Diabetes Metab 2015; 41: 55-61.","DOI":"10.1016\/j.diabet.2014.11.007"},{"key":"89091","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.diabet.2014.11.007","DOI":"10.1016\/j.diabet.2014.11.007"},{"key":"89092","doi-asserted-by":"crossref","unstructured":"Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.","DOI":"10.1001\/archderm.124.6.869"},{"key":"89093","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/archderm.1988.01670060015008","DOI":"10.1001\/archderm.1988.01670060015008"},{"key":"89094","unstructured":"Institut National de la Statistique et des Etudes Economiques. Bilan d\u00e9mographique 2017. 2018."},{"key":"89095","doi-asserted-by":"crossref","unstructured":"Deville J-C, Sarndal C-E, Sautory O. Generalized raking procedures in survey sampling. J Am Stat Assoc 1993; 88: 1013-1020.","DOI":"10.1080\/01621459.1993.10476369"},{"key":"89096","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/01621459.1993.10476369","DOI":"10.1080\/01621459.1993.10476369"},{"key":"89097","doi-asserted-by":"crossref","unstructured":"Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154-1159.","DOI":"10.1046\/j.1365-2133.2000.03541.x"},{"key":"89098","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03541.x","DOI":"10.1046\/j.1365-2133.2000.03541.x"},{"key":"89099","doi-asserted-by":"crossref","unstructured":"Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer 1996; 74: 1302-1307.","DOI":"10.1038\/bjc.1996.534"},{"key":"89100","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/bjc.1996.534","DOI":"10.1038\/bjc.1996.534"},{"key":"89101","doi-asserted-by":"crossref","unstructured":"Flohil SC, van der Leest RJ, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol 2013; 133: 1971-1978.","DOI":"10.1038\/jid.2013.134"},{"key":"89102","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/jid.2013.134","DOI":"10.1038\/jid.2013.134"},{"key":"89103","doi-asserted-by":"crossref","unstructured":"Schaefer I, Augustin M, Spehr C, Reusch M, Kornek T. Prevalence and risk factors of actinic keratoses in Germany--analysis of multisource data. J Eur Acad Dermatol Venereol 2014; 28: 309-313.","DOI":"10.1111\/jdv.12102"},{"key":"89104","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.12102","DOI":"10.1111\/jdv.12102"},{"key":"89105","doi-asserted-by":"crossref","unstructured":"Halpern AC, Kopp LJ. Awareness, knowledge and attitudes to non-melanoma skin cancer and actinic keratosis among the general public. Int J Dermatol 2005; 44: 107-111.","DOI":"10.1111\/j.1365-4632.2005.02090.x"},{"key":"89106","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-4632.2005.02090.x","DOI":"10.1111\/j.1365-4632.2005.02090.x"},{"key":"89107","doi-asserted-by":"crossref","unstructured":"MacKie RM. Awareness, knowledge and attitudes to basal cell carcinoma and actinic keratoses among the general public within Europe. J Eur Acad Dermatol Venereol 2004; 18: 552-555.","DOI":"10.1111\/j.1468-3083.2004.00993.x"},{"key":"89108","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1468-3083.2004.00993.x","DOI":"10.1111\/j.1468-3083.2004.00993.x"},{"key":"89109","doi-asserted-by":"crossref","unstructured":"Bernard P, Dupuy A, Brun P, Sasko A, Duru G, Nicoloyannis N, et al. \u00c9valuation m\u00e9dico-\u00e9conomique de la prise en charge des carcinomes basocellulaires superficiels et des k\u00e9ratoses actiniques multiples par les dermatologues fran\u00e7ais. Ann Dermatol Venereol 2007; 134: 527-533.","DOI":"10.1016\/S0151-9638(07)89263-5"},{"key":"89110","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0151-9638(07)89263-5","DOI":"10.1016\/S0151-9638(07)89263-5"},{"key":"89111","doi-asserted-by":"crossref","unstructured":"Savary J, Tine MC, Weber AC, Dorey J. Management and clinical practice of multiple face and scalp actinic keratosis in France. J Mark Access Health Policy 2019; 7: 1605787.","DOI":"10.1080\/20016689.2019.1605787"},{"key":"89112","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/20016689.2019.1605787","DOI":"10.1080\/20016689.2019.1605787"},{"key":"89113","doi-asserted-by":"crossref","unstructured":"Aggarwal I, Puyana C, Chandan N, Jetter N, Tsoukas M. Field cancerization therapies for the management of actinic keratosis: an updated review. Am J Clin Dermatol 2024; 25: 391-405.","DOI":"10.1007\/s40257-023-00839-8"},{"key":"89114","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s40257-023-00839-8","DOI":"10.1007\/s40257-023-00839-8"},{"key":"89115","doi-asserted-by":"crossref","unstructured":"Dr\u00e9no B, Amici JM, Basset-Seguin N, Cribier B, Claudel JP, Richard MA. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam\u2122 expert clinicians. J Eur Acad Dermatol Venereol 2014; 28: 1141-1149.","DOI":"10.1111\/jdv.12434"},{"key":"89116","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.12434","DOI":"10.1111\/jdv.12434"},{"key":"89117","doi-asserted-by":"crossref","unstructured":"Werner RN, Stockfleth E, Connolly SM, Correia O, Erdmann R, Foley P, et al. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version. J Eur Acad Dermatol Venereol 2015; 29: 2069-2079.","DOI":"10.1111\/jdv.13180"},{"key":"89118","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.13180","DOI":"10.1111\/jdv.13180"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/42372\/48917","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/42372\/48917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T10:09:20Z","timestamp":1737886160000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/42372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":54,"URL":"https:\/\/doi.org\/10.2340\/actadv.v105.42372","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,26]]}}}